{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Fièvre chikungunya : Questions médicales les plus fréquentes",
"headline": "Fièvre chikungunya : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Fièvre chikungunya : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-09",
"dateModified": "2025-04-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Fièvre chikungunya"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Infections à alphavirus",
"url": "https://questionsmedicales.fr/mesh/D018354",
"about": {
"@type": "MedicalCondition",
"name": "Infections à alphavirus",
"code": {
"@type": "MedicalCode",
"code": "D018354",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.782.930.100"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Fièvre chikungunya",
"alternateName": "Chikungunya Fever",
"code": {
"@type": "MedicalCode",
"code": "D065632",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Angela Luzia Branco Pinto Duarte",
"url": "https://questionsmedicales.fr/author/Angela%20Luzia%20Branco%20Pinto%20Duarte",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Medicina Clínica, Universidade Federal de Pernambuco, Recife, PE, Brasil."
}
},
{
"@type": "Person",
"name": "Claudia Diniz Lopes Marques",
"url": "https://questionsmedicales.fr/author/Claudia%20Diniz%20Lopes%20Marques",
"affiliation": {
"@type": "Organization",
"name": "Serviço de Reumatologia - Hospital das Clínicas da Universidade Federal de Pernambuco, Núcleo de Pesquisa em Inovação Terapêutica Suely Galdino (Nupit-SG)/ UFPE, Endereço: Av. Prof. Moraes Rego, 1235 - Cidade Universitária, Recife, PE, CEP: 50670-901, Brazil."
}
},
{
"@type": "Person",
"name": "Scott C Weaver",
"url": "https://questionsmedicales.fr/author/Scott%20C%20Weaver",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Nara Gualberto Cavalcanti",
"url": "https://questionsmedicales.fr/author/Nara%20Gualberto%20Cavalcanti",
"affiliation": {
"@type": "Organization",
"name": "Serviço de Reumatologia - Hospital das Clínicas da Universidade Federal de Pernambuco, Núcleo de Pesquisa em Inovação Terapêutica Suely Galdino (Nupit-SG)/ UFPE, Endereço: Av. Prof. Moraes Rego, 1235 - Cidade Universitária, Recife, PE, CEP: 50670-901, Brazil. Electronic address: nara.gual@gmail.com."
}
},
{
"@type": "Person",
"name": "Moacyr Jesus Barreto de Melo Rêgo",
"url": "https://questionsmedicales.fr/author/Moacyr%20Jesus%20Barreto%20de%20Melo%20R%C3%AAgo",
"affiliation": {
"@type": "Organization",
"name": "Serviço de Reumatologia - Hospital das Clínicas da Universidade Federal de Pernambuco, Núcleo de Pesquisa em Inovação Terapêutica Suely Galdino (Nupit-SG)/ UFPE, Endereço: Av. Prof. Moraes Rego, 1235 - Cidade Universitária, Recife, PE, CEP: 50670-901, Brazil."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A randomized controlled trial evaluating the effects of motivational interviewing in new hearing aid users (MI-HAT): study protocol for a randomized controlled trial.",
"datePublished": "2023-05-22",
"url": "https://questionsmedicales.fr/article/37217960",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13063-023-07352-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Protocol for a randomized controlled trial: exercise-priming of CBT for depression (the CBT+ trial).",
"datePublished": "2024-10-07",
"url": "https://questionsmedicales.fr/article/39375728",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13063-024-08495-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Understanding explanatory and pragmatic trials: Examples from randomized controlled trials on vertebroplasty.",
"datePublished": "2022-12-23",
"url": "https://questionsmedicales.fr/article/36566693",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neuchi.2022.101403"
}
},
{
"@type": "ScholarlyArticle",
"name": "Emulating Randomized Controlled Trials with Hybrid Control Arms in Oncology: A Case Study.",
"datePublished": "2023-01-22",
"url": "https://questionsmedicales.fr/article/36606735",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cpt.2841"
}
},
{
"@type": "ScholarlyArticle",
"name": "Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial.",
"datePublished": "2022-07-08",
"url": "https://questionsmedicales.fr/article/35804404",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13063-022-06365-y"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies virales",
"item": "https://questionsmedicales.fr/mesh/D014777"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections à virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012327"
},
{
"@type": "ListItem",
"position": 5,
"name": "Infections à Togaviridae",
"item": "https://questionsmedicales.fr/mesh/D014036"
},
{
"@type": "ListItem",
"position": 6,
"name": "Infections à alphavirus",
"item": "https://questionsmedicales.fr/mesh/D018354"
},
{
"@type": "ListItem",
"position": 7,
"name": "Fièvre chikungunya",
"item": "https://questionsmedicales.fr/mesh/D065632"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Fièvre chikungunya - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Fièvre chikungunya",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Fièvre chikungunya",
"description": "Comment diagnostiquer la fièvre chikungunya ?\nQuels tests sont utilisés pour confirmer l'infection ?\nQuels symptômes indiquent une infection ?\nLa fièvre chikungunya est-elle confondue avec d'autres maladies ?\nQuel est le délai d'apparition des symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D065632?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Fièvre chikungunya",
"description": "Quels sont les symptômes principaux de la fièvre chikungunya ?\nLa douleur articulaire est-elle persistante ?\nY a-t-il des symptômes gastro-intestinaux ?\nLes symptômes varient-ils selon l'âge ?\nPeut-on avoir des symptômes sans fièvre ?",
"url": "https://questionsmedicales.fr/mesh/D065632?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Fièvre chikungunya",
"description": "Comment prévenir la fièvre chikungunya ?\nLes moustiquaires sont-elles efficaces ?\nFaut-il éliminer les eaux stagnantes ?\nLes vaccins existent-ils pour cette maladie ?\nComment se protéger lors de voyages ?",
"url": "https://questionsmedicales.fr/mesh/D065632?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Fièvre chikungunya",
"description": "Quel est le traitement recommandé pour la fièvre chikungunya ?\nLes anti-inflammatoires sont-ils efficaces ?\nFaut-il se reposer pendant la maladie ?\nDes remèdes naturels sont-ils utiles ?\nQuand consulter un médecin ?",
"url": "https://questionsmedicales.fr/mesh/D065632?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Fièvre chikungunya",
"description": "Quelles sont les complications possibles de la fièvre chikungunya ?\nLa fièvre chikungunya peut-elle être mortelle ?\nLes personnes âgées sont-elles plus à risque ?\nY a-t-il des risques de co-infection ?\nComment gérer les douleurs chroniques post-chikungunya ?",
"url": "https://questionsmedicales.fr/mesh/D065632?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Fièvre chikungunya",
"description": "Qui est le plus à risque de contracter la maladie ?\nLes femmes enceintes sont-elles plus vulnérables ?\nLes personnes immunodéprimées sont-elles à risque ?\nLes enfants sont-ils plus touchés ?\nLes voyages dans des zones endémiques augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D065632?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la fièvre chikungunya ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur les symptômes cliniques et des tests sérologiques ou PCR."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer l'infection ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques détectent les anticorps, tandis que la PCR identifie le virus."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleurs articulaires, éruptions cutanées et fatigue sont des indicateurs clés."
}
},
{
"@type": "Question",
"name": "La fièvre chikungunya est-elle confondue avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec la dengue ou le virus Zika en raison de symptômes similaires."
}
},
{
"@type": "Question",
"name": "Quel est le délai d'apparition des symptômes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes apparaissent généralement 4 à 8 jours après la piqûre d'un moustique infecté."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux de la fièvre chikungunya ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs articulaires, maux de tête et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "La douleur articulaire est-elle persistante ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur articulaire peut persister plusieurs mois après la guérison initiale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes gastro-intestinaux ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des nausées ou des vomissements peuvent survenir, mais sont moins fréquents."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants et les personnes âgées peuvent présenter des symptômes plus sévères et prolongés."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans fièvre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent éprouver des douleurs articulaires sans fièvre initiale."
}
},
{
"@type": "Question",
"name": "Comment prévenir la fièvre chikungunya ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les piqûres de moustiques en utilisant des répulsifs et en portant des vêtements longs."
}
},
{
"@type": "Question",
"name": "Les moustiquaires sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les moustiquaires traitées avec insecticide protègent contre les piqûres de moustiques."
}
},
{
"@type": "Question",
"name": "Faut-il éliminer les eaux stagnantes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éliminer les eaux stagnantes réduit les lieux de reproduction des moustiques."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils pour cette maladie ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin approuvé contre la fièvre chikungunya."
}
},
{
"@type": "Question",
"name": "Comment se protéger lors de voyages ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisez des répulsifs, portez des vêtements longs et choisissez des hébergements protégés."
}
},
{
"@type": "Question",
"name": "Quel est le traitement recommandé pour la fièvre chikungunya ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique; les soins sont symptomatiques."
}
},
{
"@type": "Question",
"name": "Les anti-inflammatoires sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anti-inflammatoires non stéroïdiens peuvent soulager la douleur et l'inflammation."
}
},
{
"@type": "Question",
"name": "Faut-il se reposer pendant la maladie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un repos adéquat est conseillé pour aider à la récupération et réduire la fatigue."
}
},
{
"@type": "Question",
"name": "Des remèdes naturels sont-ils utiles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains remèdes naturels peuvent aider à soulager les symptômes, mais peu de preuves existent."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si les symptômes s'aggravent ou si des complications apparaissent."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la fièvre chikungunya ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des douleurs articulaires chroniques et des problèmes neurologiques."
}
},
{
"@type": "Question",
"name": "La fièvre chikungunya peut-elle être mortelle ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fièvre chikungunya n'est généralement pas mortelle, mais des complications peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent développer des complications plus graves et prolongées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de co-infection ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la co-infection avec d'autres virus comme la dengue peut compliquer le tableau clinique."
}
},
{
"@type": "Question",
"name": "Comment gérer les douleurs chroniques post-chikungunya ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut des traitements anti-inflammatoires et des thérapies physiques."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque de contracter la maladie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes vivant dans des zones endémiques et celles exposées aux moustiques sont à risque."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles plus vulnérables ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes enceintes peuvent avoir des complications plus graves et affecter le fœtus."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées peuvent développer des formes plus sévères de la maladie."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus touchés ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent contracter la maladie, mais les symptômes sont souvent moins sévères."
}
},
{
"@type": "Question",
"name": "Les voyages dans des zones endémiques augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones où le chikungunya est présent augmente le risque d'infection."
}
}
]
}
]
}
Hearing loss is the third leading global cause of disability and is associated with poorer quality of life. Hearing aids are often recommended for hearing loss; however, hearing aid uptake and use rat...
A multi-center, prospective, randomized patient-blind controlled trial with a pre- and post-tests design. New hearing aid users ≥ 18 years of age will be recruited from Vancouver, Canada. They will be...
This trial is designed to evaluate the efficacy of one-on-one MI in improving hearing aid use in new adult users in the short and long terms. Results will contribute to the evidence on whether MI coun...
ClinicalTrials.gov NCT04673565 . Registered on 17 December 2020....
Depression is a leading cause of disability worldwide, and treatments could be more effective. Identifying methods to improve treatment success has the potential to reduce disease burden dramatically....
The CBT + trial will be a parallel-arm randomized controlled trial that will recruit 40 adult participants with DSM-5 diagnosed depression (verified with clinical interview) via referrals, mass emails...
The novel approach of priming CBT with moderate-intensity aerobic exercise evaluated in a randomized controlled trial (CBT + trial) has the potential to demonstrate the usefulness of exercise as an au...
ClinicalTrials.gov NCT06001346 . Registered on August 21, 2023....
To better understand the explanatory-pragmatic distinction in the design and interpretation of randomized controlled trials (RCTs)....
We review the explanatory-pragmatic distinction in clinical trial design. We use the PRECIS-2 tool to evaluate the trial design of selected RCTs on percutaneous vertebroplasty for osteoporotic vertebr...
The selection of criteria and the scoring of multiple PRECIS domains were subjective and thus debatable. The pragmascope patterns of various vertebroplasty trials were heterogeneous. Many trials had b...
The results of a trial cannot be interpreted without understanding the various design choices made along the explanatory-pragmatic spectrum....
This proof-of-concept study retrospectively assessed the feasibility of applying a hybrid control arm design to a completed phase III randomized controlled trial (RCT; CheckMate-057) in advanced non-s...
Lingual microcystic lymphatic malformations (LMLMs) are rare congenital vascular malformations presenting as clusters of cysts filled with lymph fluid or blood. Even small well-limited lesions can be ...
This is a randomized, multicentric study using an individually randomized stepped-wedge design over 24 weeks to evaluate topical application of a 1 mg/mL sirolimus solution once daily, on LMLM, versus...
Given the disappointing state of current treatment options in LMLMs, topical sirolimus could become firstline therapy in treating LMLMs if its efficacy and safety were to be demonstrated....
ClinicalTrials.gov NCT04128722 . Registered on 24 September 2019. EudraCT: EUCTR2019-001530-33-FR Sponsor (University Hospital Center of Tours - CHRU Tours): DR190041-TOPGUN French regulatory authorit...
Allergic rhinitis (AR) is the inflammation of the membranes lining the nose due to allergen exposure and is characterized by sneezing, nasal congestion, itching of the nose, or postnasal discharge. Th...
The primary aim is to assess the efficacy of Ayurvedic management for AR (or vataja pratishyaya) by comparing it to a conventional control group. The secondary aims are to determine the mean change in...
This ongoing study is an open-label randomized controlled interventional trial, with a sample size of 90 both in the trial and standard control group (including dropouts, 20%), and will be carried out...
As of May 2024, 72 patients have been enrolled in both groups. Data analysis should be completed by February 2025. The study will be reported following standard guidelines for reporting randomized con...
The Ayurvedic approach could be an evidence-based therapeutic tactic for the management of AR....
Clinical Trials Registry India CTRI/2023/06/053395; https://tinyurl.com/564d2zz8....
DERR1-10.2196/56063....
Contemporary management of uncomplicated type B aortic dissections (uTBAD) is based on the acuity and various morphological features. Medical therapy is mandatory, while the risks of early thoracic en...
The trial is a randomized, open-label, superiority clinical trial with parallel assignment of subjects at 23 clinical sites in Denmark, Norway, Sweden, Finland, and Iceland. Eligibility includes patie...
This trial will evaluate the primary question of whether early TEVAR improves survival at 5 years among uTBAD patients. Moreover, the costs and the impact on quality of life should provide sorely need...
ClinicalTrials.gov NCT05215587. Registered on January 31, 2022....
With advances in antiretroviral therapy, people with HIV (PWH) are living longer and are less likely to die from AIDS-related complications. Yet, prior research has shown that smoking is often not add...
The current study is a type 1 hybrid effectiveness-implementation trial to evaluate the impact of a proactive, opt-out tobacco treatment intervention on cessation outcomes and advance understanding of...
This study will examine a novel approach to optimizing tobacco treatment delivery for PWH. Integrating effectiveness and implementation results will help define best practices for engaging PWH with ev...
ClinicalTrials.gov: NCT05019495 (August 24, 2021)....
Glaucoma is a chronic progressive optic neuropathy that necessitates lifelong treatment to reduce the decline of the optic nerve. Due to the extended and continuous treatments required for patients, c...
The primary objective of this study is to conduct a single-center randomized control trial involving patients with glaucoma. Acupuncture will be evaluated as an adjunctive therapy. The trial aims to e...
In this single-center randomized controlled trial, participants (N=50) with primary open-angle glaucoma will be randomly assigned to the treatment group, receiving ophthalmic acupuncture with "De Qi" ...
Recruitment of participants for the trial commenced on June 28, 2023. A total of 10 participants have been enrolled to test the feasibility of the experiment. We anticipate that the preliminary data f...
This trial uses rigorous methodology and comprehensive outcome measurements to assess the clinical efficacy of acupuncture as an adjunctive therapy for glaucoma, providing valuable insights for future...
ClinicalTrials.gov NCT05753137; https://clinicaltrials.gov/study/NCT05753137....
DERR1-10.2196/57888....
Investigators often conduct randomized controlled trials (RCTs) at multiple centers/sites when determining the effect of a treatment or an intervention. Diversifying recruitment across multiple instit...